0001415889-24-020012.txt : 20240723 0001415889-24-020012.hdr.sgml : 20240723 20240723214006 ACCESSION NUMBER: 0001415889-24-020012 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240720 FILED AS OF DATE: 20240723 DATE AS OF CHANGE: 20240723 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brophy Michael Burkes CENTRAL INDEX KEY: 0001697362 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37478 FILM NUMBER: 241135951 MAIL ADDRESS: STREET 1: 201 INDUSTRIAL ROAD, SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Natera, Inc. CENTRAL INDEX KEY: 0001604821 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 010894487 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 13011 MCCALLEN PASS STREET 2: BUILDING A SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78753 BUSINESS PHONE: 650-249-9090 MAIL ADDRESS: STREET 1: 13011 MCCALLEN PASS STREET 2: BUILDING A SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78753 4 1 form4-07232024_090702.xml X0508 4 2024-07-20 0001604821 Natera, Inc. NTRA 0001697362 Brophy Michael Burkes C/O NATERA, INC. 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 false true false false CHIEF FINANCIAL OFFICER 1 Common Stock 2024-07-20 4 M 0 1522 A 76581 D Common Stock 2024-07-21 4 M 0 1145 A 77726 D Common Stock 2024-07-22 4 M 0 1250 A 78976 D Common Stock 2024-07-22 4 S 0 1059 105.1596 D 77917 D Common Stock 2024-07-23 4 S 0 499 107.3979 D 77418 D Restricted Stock Unit 2024-07-20 4 M 0 1522 0 D Common Stock 1522 9131 D Restricted Stock Unit 2024-07-21 4 M 0 1145 0 D Common Stock 1145 2290 D Restricted Stock Unit 2024-07-22 4 M 0 1250 0 D Common Stock 1250 6250 D Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021 and January 28, 2022, respectively.. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.90 to $105.16 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on October 22, 2021. The RSUs vest over four years. 25% of the RSUs vested on January 20, 2023 and the remaining shares vest in 12 equal quarterly installments thereafter. The RSUs vest over four years. 25% of the RSUs vested on January 21, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter. The RSUs vest over four years. 25% of the RSUs vested on October 22, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter. /s/ Tami Chen, Attorney-in-Fact 2024-07-23